
Continuous Renal Replacement Therapy Machine Market Report 2026
Global Outlook – By Type (Mobile, Fixed), By Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)), By Age Group (Pediatric, Adult, Geriatric), By Application (Acute Renal Failure, Chronic Renal Failure, Other Applications), By End-User (Hospital, Clinic, Dialysis Center, Home Care, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Continuous Renal Replacement Therapy Machine Market Overview
• Continuous Renal Replacement Therapy Machine market size has reached to $1.37 billion in 2025 • Expected to grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Increasing Incidence of Acute Kidney Injury Fuels Growth of the Continuous Renal Replacement Therapy Machine Market • Market Trend: Integration Of Advanced Therapies For Enhanced Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Continuous Renal Replacement Therapy Machine Market?
Continuous renal replacement therapy (CRRT) machines are specialized medical devices used to provide continuous, slow, and controlled dialysis treatment to critically ill patients with acute kidney injury (AKI) or severe fluid overload, typically in an intensive care unit (ICU) setting. Unlike traditional dialysis, which is usually performed intermittently, CRRT operates continuously over 24 hours, making it gentler on unstable patients. CRRT machines help manage and replace the filtration function of the kidneys in critically ill patients whose kidneys are unable to perform adequately due to acute injury or illness. The main types in the continuous renal replacement therapy machine market are mobile and fixed. Mobile continuous renal replacement therapy machines are designed for easy transport and use across different hospital units. The various modalities include slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These machines serve different age groups, including pediatric, adult, and geriatric patients. These are used for various applications, such as treating acute renal failure, chronic renal failure, and others, and end-users include hospitals, clinics, dialysis centers, home care settings, and others.
What Is The Continuous Renal Replacement Therapy Machine Market Size and Share 2026?
The continuous renal replacement therapy machine market size has grown strongly in recent years. It will grow from $1.37 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising incidence of acute kidney injury in icu settings, increasing prevalence of sepsis and multi-organ failure, expansion of critical care infrastructure, growing adoption of continuous renal support therapies, improved survival rates among critically ill patients.What Is The Continuous Renal Replacement Therapy Machine Market Growth Forecast?
The continuous renal replacement therapy machine market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to aging population with higher aki risk, increasing demand for gentle renal replacement therapies, rising icu admission rates globally, growing focus on individualized critical care treatment, expansion of advanced critical care facilities in emerging markets. Major trends in the forecast period include rising adoption of crrt machines in intensive care units, increasing demand for continuous dialysis in hemodynamically unstable patients, growing preference for mobile and portable crrt machines, expansion of crrt use across pediatric and geriatric care, increasing focus on precision fluid and solute management.Global Continuous Renal Replacement Therapy Machine Market Segmentation
1) By Type: Mobile, Fixed 2) By Modality: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF) 3) By Age Group: Pediatric, Adult, Geriatric 4) By Application: Acute Renal Failure, Chronic Renal Failure, Other Applications 5) By End-User: Hospital, Clinic, Dialysis Center, Home Care, Other End-Users Subsegments: 1) By Mobile: Compact Mobile CRRT Machine, Portable CRRT Machine 2) By Fixed: Standard Fixed CRRT Machine, High-Performance Fixed CRRT MachineWhat Is The Driver Of The Continuous Renal Replacement Therapy Machine Market?
The rising prevalence of acute kidney injury is expected to propel the growth of the continuous renal replacement therapy machine market going forward. Acute kidney injury (AKI) is a sudden decline in kidney function, leading to an inability to filter waste and maintain fluid and electrolyte balance effectively. Acute kidney injury (AKI) combines problems that arise due to decreased blood flow to the kidneys, direct damage from toxins or infection, and obstruction in the urinary tract. Continuous renal replacement therapy (CRRT) machines help provide continuous and gentle dialysis, which gradually removes waste products and excess fluids from the blood, helping to stabilize the patient's condition and prevent further complications. For instance, in June 2023, Kidney Research, a UK-based charity, estimated that there were 615,000 cases of acute kidney injury in 2022. Moreover, by 2033, the number of cases is projected to increase by 4% to 637,000. Therefore, the rising prevalence of acute kidney injury is driving the continuous renal replacement therapy machine industry.Key Players In The Global Continuous Renal Replacement Therapy Machine Market
Major companies operating in the continuous renal replacement therapy machine market are Medtronic plc, Fresenius Medical Care AG KGaA, GE HealthCare Technologies Inc., Baxter International Inc., Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Nipro Corporation, B Braun Medical Inc., Shandong Weigao Blood Purification Products Co Ltd, Nikkiso Co Ltd, JMS Co Ltd, NxStage Medical Inc., Guangdong Biolight Meditech Co Ltd, Quanta Dialysis Technologies Ltd, Medica S.p.A., Anjue Medical Equipment Co Ltd, Infomed SA, SWS Hemodialysis Care Co Ltd, Kawasumi Laboratories Incorporated, Toray Industries IncGlobal Continuous Renal Replacement Therapy Machine Market Trends and Insights
Major companies in the continuous renal replacement therapy (CRRT) machine market are focusing on technological advancements, such as integrating augmented reality (AR), to enhance real-time monitoring and improve clinical outcomes for patients. Augmented reality (AR) in continuous renal replacement therapy (CRRT) machines is being explored to enhance visualization of patient data, support real-time monitoring, and improve clinical decision-making by overlaying critical information directly into the practitioner's field of view. For instance, in March 2024, Fresenius Medical Care, a Germay-based leading healthcare company, introduced an innovative augmented reality (AR) training program designed specifically for its Continuous Kidney Replacement Therapy device, the multi-Filtrate PRO. This program was unveiled during the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.What Are Latest Mergers And Acquisitions In The Continuous Renal Replacement Therapy Machine Market?
In September 2025, Quanta Dialysis Technologies Ltd., a UK-based medical technology company, partnered with Innovative Renal Care to increase the availability of advanced dialysis treatments, including CRRT, for patients across the United States. With this partnership aims to broaden access to innovative dialysis solutions, enhance continuous renal replacement therapy capabilities, and improve patient outcomes across US acute care and hospital settings. Innovative Renal Care is a US-based kidney care company that offers continuous renal replacement therapy.Regional Outlook
North America was the largest region in the continuous renal replacement therapy machine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Continuous Renal Replacement Therapy Machine Market?
The continuous renal replacement therapy machine market consists of sales of blood tubing sets, dialyzers or hemofilters, replacement fluids, anticoagulants, and vascular access catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Continuous Renal Replacement Therapy Machine Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.49 billion |
| Revenue Forecast In 2035 | $2.07 billion |
| Growth Rate | CAGR of 8.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Modality, Age Group, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Medtronic plc, Fresenius Medical Care AG KGaA, GE HealthCare Technologies Inc., Baxter International Inc., Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Nipro Corporation, B Braun Medical Inc., Shandong Weigao Blood Purification Products Co Ltd, Nikkiso Co Ltd, JMS Co Ltd, NxStage Medical Inc., Guangdong Biolight Meditech Co Ltd, Quanta Dialysis Technologies Ltd, Medica S.p.A., Anjue Medical Equipment Co Ltd, Infomed SA, SWS Hemodialysis Care Co Ltd, Kawasumi Laboratories Incorporated, Toray Industries Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
